Insider · CIK 0001638744

Ng George K

Reports to the SEC for 4 companies · VERO BEACH, FL

sec.gov

Transactions

Companies

Filings

CIK

0001638744

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-08	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,600 sh	—	—	17,092
2026-08-08	PCSAProcessa Pharmaceuticals, Inc. · Restricted StockM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,600 sh	—	—	19,624
2026-07-26	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+9,384 sh	—	—	21,224
2026-07-01	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,057 sh	$1.93	+$5,900.01	15,492
2026-06-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,465 sh	$2.22	+$5,472.3	12,435
2026-05-29	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,129 sh	$2.57	+$5,471.53	9,970
2026-05-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,843 sh	$2.97	+$5,473.71	7,841
2026-04-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,034 sh	$2.69	+$5,471.46	6,013
2026-04-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,843 sh	$2.97	+$5,473.71	5,492
2026-04-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,843 sh	$2.97	+$5,473.71	3,979
2026-04-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,843 sh	$2.97	+$5,473.71	3,979
2026-03-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,136 sh	$2.54	+$5,414.76	2,136
2026-03-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,136 sh	$2.54	+$5,414.76	3,649
2026-02-12	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+156K sh	—	—	156,240
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+256K sh	—	—	256,000
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+768K sh	—	—	768,000
2025-07-24	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+1.82M sh	—	—	1,922,471
2025-01-29	PCSAProcessa Pharmaceuticals, Inc. · WarrantsA Award	Director, Chief Executive Officer	AAward	+87.2K sh	—	—	87,200
2025-01-29	PCSAProcessa Pharmaceuticals, Inc. · WarrantsA Award	Director, Chief Executive Officer	AAward	+43.6K sh	—	—	43,600
2025-01-27	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+87.2K sh	$0.80	+$69.5K	87,200
2025-01-02	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+51.3K sh	—	—	51,275
2024-10-18	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+35.8K sh	—	—	35,780
2024-10-18	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,553
2024-10-18	HURATuHURA Biosciences, Inc./NV · Options (Right to Buy)A Award	Director	AAward	+13.6K sh	—	—	13,553
2024-01-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$2.70	+$27K	20,000
2023-10-12	PCSAProcessa Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	$0.25	+$25K	200,000
2023-10-10	PCSAProcessa Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+100K sh	$0.25	+$25K	100,000
2023-08-08	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	800,000
2023-08-08	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+400K sh	—	—	400,000
2018-02-28	Sorrento Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+90K sh	$9.95	+$895K	101,453
2018-02-28	Sorrento Therapeutics, Inc.J Other	See Remarks	JOther	+163K sh	—	—	302,146
2017-09-14	Sorrento Therapeutics, Inc.Stock OptionsA Award	See Remarks	AAward	+150K sh	—	—	150,000
2017-09-11	Sorrento Therapeutics, Inc.J Other	See Remarks	JOther	+89.3K sh	—	—	138,677
2017-02-03	Sorrento Therapeutics, Inc.S Sale	See Remarks	SSale	−40K sh	$5.15	−$206K	49,338
2016-11-08	Sorrento Therapeutics, Inc.A Award	See Remarks	AAward	+89.3K sh	—	—	90,226
2016-08-12	Sorrento Therapeutics, Inc.Stock OptionsA Award	See Remarks	AAward	+100K sh	—	—	260,000
2016-03-11	Sorrento Therapeutics, Inc.Stock OptionsA Award	See Remarks	AAward	+40K sh	—	—	160,000
2015-08-21	Sorrento Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+333 sh	$13.55	+$4,510.818	833
2015-08-21	Sorrento Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+500 sh	$13.49	+$6,745	500
2015-08-21	Sorrento Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+55 sh	$13.34	+$733.7	888
2015-08-03	Sorrento Therapeutics, Inc.P Purchase	See Remarks	PPurchase	+11.5K sh	$11.50	+$132K	14,901

Recent filings

Accepted (ET)
Aug 114
Ng George K0000897069-26-001602
SEC(opens sec.gov)
Jul 284
Ng George K0000897069-26-001554
SEC(opens sec.gov)
Jul 14
Ng George K0000897069-26-001480
SEC(opens sec.gov)
Jun 164
Ng George K0000897069-26-001410
SEC(opens sec.gov)
Jun 14
Ng George K0000897069-26-001291
SEC(opens sec.gov)
May 194/A
Ng George K0000897069-26-001167
SEC(opens sec.gov)
May 194
Ng George K0000897069-26-001186
SEC(opens sec.gov)
May 14
Ng George K0000897069-26-001006
SEC(opens sec.gov)
Apr 304/A
Ng George K0000897069-26-000979
SEC(opens sec.gov)
Apr 304/A
Ng George K0000897069-26-000977
SEC(opens sec.gov)
Apr 174
Ng George K0000897069-26-000910
SEC(opens sec.gov)
Apr 14
Ng George K0000897069-26-000750
SEC(opens sec.gov)
Feb 174
Ng George K0000897069-26-000367
SEC(opens sec.gov)
Oct 34
Ng George K0000897069-25-001543
SEC(opens sec.gov)
Jul 284
Ng George K0000897069-25-001213
SEC(opens sec.gov)
Feb 184/A
Ng George K0000897069-25-000290
SEC(opens sec.gov)
Jan 294
Ng George K0000897069-25-000134
SEC(opens sec.gov)

Companies

Address

C/O PROCESSA PHARMACEUTICALS, INC. 601 21ST STREET SUITE 300

VERO BEACH, FL, 32960